C4 Therapeutics saw the highest growth of 249% in patent filings in November and 199% in grants in October in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 49% and grants by 199%. GlobalData’s DataBook provides a comprehensive analysis of C4 Therapeutics‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

C4 Therapeutics has been focused on protecting inventions in United States(US) with six publications in Q4 2023

The United States(US) Patent Office dominates the patent filings and grants with nearly 33% filings and 100% grants. The United States(US), Australia(AU), Argentina(AR), and World Intellectual Property Organization(WIPO) patent Office are among the top ten patent offices where C4 Therapeutics is filings its patents. Among the top granted patent authorities, C4 Therapeutics has 100% of its grants in United States(US)

Patents related to rare diseases lead C4 Therapeutics's portfolio

C4 Therapeutics has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and no patents were granted in Q4 2023.

Breast cancer related patents lead C4 Therapeutics portfolio followed by leukemia, and melanoma

C4 Therapeutics has highest number of patents in breast cancer followed by leukemia, melanoma, uterine cancer, and glioma.

For comprehensive analysis of C4 Therapeutics's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.